MariMed Inc.
General ticker "MRMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $44.2M (TTM average)
MariMed Inc. follows the US Stock Market performance with the rate: 25.1%.
Estimated limits based on current volatility of 5.0%: low 0.08$, high 0.09$
Factors to consider:
- Total employees count: 832 (+15.4%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Expansion risks, Market competition, Labor/talent shortage/retention, Agricultural risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.06$, 0.20$]
- 2025-12-31 to 2026-12-31 estimated range: [0.05$, 0.18$]
Financial Metrics affecting the MRMD estimates:
- Positive: with PPE of -5.9 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 1.84
- Positive: Operating cash flow per share per price, % of 14.85 > 13.24
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term MRMD quotes
Long-term MRMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $134.01MM | $148.60MM | $157.96MM |
| Operating Expenses | $113.64MM | $134.21MM | $155.05MM |
| Operating Income | $20.37MM | $14.38MM | $2.91MM |
| Non-Operating Income | $-0.86MM | $-20.98MM | $-6.88MM |
| Interest Expense | $1.69MM | $9.19MM | $6.94MM |
| Income(Loss) | $19.51MM | $-6.60MM | $-3.97MM |
| Taxes | $5.89MM | $9.41MM | $8.16MM |
| Profit(Loss)* | $13.47MM | $-16.03MM | $-12.16MM |
| Stockholders Equity | $57.31MM | $69.91MM | $59.88MM |
| Inventory | $19.48MM | $25.31MM | $33.49MM |
| Assets | $152.20MM | $196.12MM | $206.99MM |
| Operating Cash Flow | $7.31MM | $7.91MM | $6.79MM |
| Capital expenditure | $12.74MM | $20.13MM | $12.67MM |
| Investing Cash Flow | $-26.24MM | $-25.98MM | $-17.13MM |
| Financing Cash Flow | $-1.01MM | $22.98MM | $2.98MM |
| Earnings Per Share** | $0.04 | $-0.04 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.